Cellular Biomedicine Group

15May

Addition of a Second Clinical Site in the Expansion of its Chimeric Antigen Receptor T-cell (CAR-T) Phase I Clinical Trial for Its CARD-1 Trial

8May

First Quarter 2017 Financial Results and Business Highlights

1May

Results of 2017 Annual Meeting of Stockholders

10Apr

CBMG and GE Healthcare Life Sciences China Announce Strategic Partnership

30Mar

Completion of Wuxi GMP Facility Expansion

21Mar

2017 Annual Meeting

14Mar

Full-Year 2016 Financial Results and Recent Operational Progress

27Feb

CBMG Awarded $2.29 Million Grant from the California Institute for Regenerative Medicine

7Feb

CBMG to Present at the 19th BIO CEO & Investor Conference on February 13, 2017

9Jan

Phase I Trial (CALL-1) for C-CAR011 in Adult Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia (ALL) in China